LICENSE AGREEMENTLicense Agreement • September 23rd, 2024 • BioAtla, Inc. • Biological products, (no disgnostic substances) • New York
WHEREAS, subject to the terms and conditions of this Agreement, Context desires to develop, distribute, market and sell the Program Products in the Territory; and
GLOBAL TRANSACTION AGREEMENTGlobal Transaction Agreement • September 23rd, 2024 • BioAtla, Inc. • Biological products, (no disgnostic substances) • New York
This Global Transaction Agreement (the “Global Transaction Agreement”) is effective as of September 23rd, 2024, (the “Effective Date”), by and between BioAtla, Inc., a Delaware corporation having a place of business at 11085 Torreyana Road, San Diego, CA 92121 (“BioAtla”) and Himalaya Therapeutics SEZC a Cayman entity with an address at Strathvale House, 90 N Church St, George Town, Cayman Islands (“Himalaya”). Except where expressly set forth to the contrary in this Global Transaction Agreement, capitalized terms that are used but not defined herein shall have the meaning ascribed to such terms in the ERA (as defined below).
